The study looked at 12 rooms of patients with multidrug-resistant organisms and 10 cubicles in the medical, surgical, neurosurgical, orthopedics and rehabilitation units of 10 hospitals.
To determine the efficacy of two types of antimicrobial privacy curtains in clinical settings compared to standard curtains, the researchers collected culture samples from curtain surfaces twice a week for two weeks, followed by weekly intervals.
The second type of antimicrobial curtain (antimicrobial curtain B) was highly effective at reducing the number of bacteria living on the surface compared to the standard curtain.
The percentages of multidrug-resistant organism contamination, including methicillin-resistant Staphylococcus aureus, were also significantly lower on antimicrobial curtain B than the standard curtain.
Antimicrobial curtain A, which had built-in silver, was not effective at reducing the microbial burden, the researchers found.
More articles on clinical leadership and infection control:
7 health issues CDC tackled in 2018
Meditation, exercise could help prevent flu, study finds
7 risk factors for treatment failure among complicated UTI patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.